These man-made molecules also were effective against the abnormal protein that causes Machado-Joseph disease, a neurological condition similar to Huntington’s.
The researchers’ approach relies on interfering with the steps by which genetic information in cells is “translated” from DNA to make proteins, which carry out vital biological functions.
Huntington’s and Machado-Joseph are fatal inherited diseases caused by abnormal repeats of a small segment in a person’s DNA, or genetic code, represented by the letters CAG. These mutations result in the body producing malfunctioning proteins that cause the diseases. The more repeats, the worse the disease, and the earlier in life it appears. A person with the disease carries one normal copy of the gene and one mutated copy in his or her cells.
In Huntington’s, this CAG repeat occurs in a gene called huntingtin, and in Machado-Joseph, it occurs in a gene called ataxin-3. A person with Huntington’s can have up to 100 CAG repeats. CAG repeats are involved in several other neurodegenerative diseases, including Fragile X syndrome, the most common form of mental retardation, and myotonic dystrophy.
While these genes are best known for the devastating effects of their mutated forms, their normal forms are essential for embryonic development, nerve function and other bodily processes. Any treatment that interferes with the mutant forms must leave the normal forms as unaffected as possible, Dr. Corey said.
“Attempting to intervene is very risky, but because the problem is important, it’s worth doing,” he said.
In the current study, the researchers created short lengths of molecules that resemble ribonucleic acid (RNA), the chemical cousin of DNA. These mimics, called PNAs and LNAs, were specifically designed to bind to CAG repeats, preventing cells from creating the abnormal proteins. The researchers also designed short lengths of RNA called small interfering RNA, or siRNA, to interfere with CAG repeats.
In cells from Huntington’s patients, the PNAs, LNAs and siRNAs decreased the amount of mutant protein produced, in some cases up to 100 percent. The effect was greatest when the compounds interfered with long lengths of CAG repeats; the effectiveness varied, however, among cells taken from different patients.
Some forms of these compounds left the normal forms of huntingtin and ataxin-3 proteins undisturbed, but other compounds partly or completely blocked their formation. In some cells, some of the RNA mimics drastically cut the production of both mutant and normal proteins – an undesirable effect, Dr. Corey said.
These findings indicate that further tweaking of the molecular structures of the RNA mimics will be needed to minimize the effects on normal proteins.
“It is encouraging that small chemical changes could substantially enhance selectivity,” Dr. Corey said. “If we can test a handful of compounds and identify better ones, we have reason to believe that more testing will continue to produce significant improvement.”
Because this study was done in cultured cells, and not in whole animals or humans, it does not indicate how much of the abnormal proteins must be blocked to treat the disease effectively, he said. “Fifty percent inhibition might be enough, but that remains to be determined,” Dr. Corey said.
In future studies, the researchers plan to try these RNA mimics in whole animals, using several different mutations of the genes.
Laurie Tompkins, who oversees neurogenetics grants at the National Institutes of Health’s National Institute of General Medical Sciences, said the ability to control individual genes makes this work stand out.
“By exploiting processes that occur in normal cells, Dr. Corey has come up with a clever way to do this that may well lead to new ways to combat Huntington’s and other related diseases,” she said.
Other UT Southwestern researchers from the Department of Pharmacology involved in the study were co-lead authors Dr. Jiaxin Hu, assistant instructor, and Dr. Masayuki Matsui, postdoctoral researcher; Dr. Keith Gagnon, postdoctoral researcher; and graduate student Jacob Schwartz; Dr. Jun Wu, assistant instructor in physiology; and Dr. Ilya Bezprozvanny, professor of physiology, also participated, as did researchers from Sigma-Aldrich Genopole Campus in France.
The study was funded by the High-Q Foundation, the National Institutes of Health, the Welch Foundation and the Ataxia MJD Research Project Inc.
Aline McKenzie | EurekAlert!
Further reports about: > CAG > DNA > Huntington's disease > LNAs > Machado-Joseph disease > Medical Wellness > PNAS > RNA > Small Molecule > abnormal protein > bodily processes > fragile X syndrome > human cells > man-made molecules > mental retardation > molecular structure > mutant protein production > myotonic dystrophy > neurodegenerative disease > neurological condition > vital biological functions
Molecular evolution: How the building blocks of life may form in space
26.04.2018 | American Institute of Physics
Multifunctional bacterial microswimmer able to deliver cargo and destroy itself
26.04.2018 | Max-Planck-Institut für Intelligente Systeme
Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
26.04.2018 | Power and Electrical Engineering
26.04.2018 | Life Sciences
26.04.2018 | Power and Electrical Engineering